Progress towards universal health coverage in BRICS: translating economic growth into better health

Rao, Krishna D.; Petrosyan, Varduhi; Araújo, Edson; McIntyre, Di

doi:10.2471/blt.13.127951

Cited by 77 publications

(63 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although most South Africans (83%) use public health-care services, private health care accounts for 43% of total South African health expenditure. 7 …”

Section: Introductionmentioning

confidence: 99%

Establishment of a cancer surveillance programme: the South African experience

Singh¹,

Ruff²,

Babb³

et al. 2015

The Lancet Oncology

View full text Add to dashboard Cite

Cancer is projected to become a leading cause of morbidity and mortality in low-income and middle-income countries in the future. However, cancer incidence in South Africa is largely under-reported because of a lack of nationwide cancer surveillance networks. We describe present cancer surveillance activities in South Africa, and use the International Agency for Research on Cancer framework to propose the development of four population-based cancer registries in South Africa. These registries will represent the ethnic and geographical diversity of the country. We also provide an update on a cancer surveillance pilot programme in the Ekurhuleni Metropolitan District, and the successes and challenges in the implementation of the IARC framework in a local context. We examine the development of a comprehensive cancer surveillance system in a middle-income country, which might serve to assist other countries in establishing population-based cancer registries in a resource-constrained environment.

show abstract

“…Although most South Africans (83%) use public health-care services, private health care accounts for 43% of total South African health expenditure. 7 …”

Section: Introductionmentioning

confidence: 99%

Establishment of a cancer surveillance programme: the South African experience

Singh¹,

Ruff²,

Babb³

et al. 2015

The Lancet Oncology

View full text Add to dashboard Cite

show abstract

“…Beyond challenges indicated by epidemiological data (table 1), other similarities threaten TB-control efforts. The private health sector, for example, not only constitutes a substantial proportion of overall health spending (Rao et al 2014), but also offers venues where first-and second-line TB drugs are available due to lack of governmental regulation (Wells et al 2011), aiding the creation of drug-resistant forms (Gandhi et al 2010). For example, China has drastically lowered prevalence, incidence, and mortality rates from 1990 levels WHO 2014).…”

Section: Brics Health Collaboration Priorities: the Case Of Tuberculomentioning

confidence: 99%

“…Tuberculosis is positioned as a challenge to health in BRICS, the control of which has been determined to not only be the most cost-effective public health intervention (Lancet 2014), but also to positively impact national GDP (World Bank 1993; Jamison et al 2013). The solution to this challenge relies on established approaches: affordable medicines and quality care (Rao et al 2014), delivered through state-sponsored primary health care, with clear quantitative benchmarks for success. However, BRICS emphasis on innovation represents a departure from business as usual, from technological advances (new vaccines, diagnostics, and drugs) to service delivery (e-Health and tele-medicine).…”

Section: Brics Health Collaboration Priorities: the Case Of Tuberculomentioning

confidence: 99%

“…In a systematic literature review, Andrew Harmer and colleagues (2013, 1) noted an 'overwhelming tendency to describe individual BRICS countries [sic] influence' (see also Ezziane 2014). Much of the literature has concentrated on country-specific analyses (Lancet 2009(Lancet , 2011a(Lancet , 2011b(Lancet , 2012(Lancet , 2013, investigations of shared health challenges (Creswell et al 2014;Cashwell et al 2014;Ernest et al 2014;Marten et al 2014;Rao et al 2014), or opportunities for technological developments (Ezziane 2014;Kaddar, Milstien, and Schmitt 2014). Several researchers have examined BRICS health initiatives vis-à-vis global health (Fleck and Harmer 2014;Watt, Gomez, and McKee 2014;Buss, Ferreira, and Hoirisch 2014), in large part asking: 'to what extent does it make sense to talk of "the BRICS" as a coherent unit of analysis?'…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

BRICS health and tuberculosis control collaborations during an era of global health

Dirlikov¹

2015

MAT

View full text Add to dashboard Cite

In this think piece, I examine the difference introduced by BRICS (Brazil, Russia, India, China, and South Africa) health collaborations in an era of global health. Using tuberculosis control as a grounding example, I show that BRICS collaborations prioritize: state-led solutions, particularly through policies aimed at expanding universal health coverage; scientific and programmatic innovation; experience and technology sharing; clear benchmarks for progress, based on current best practices of control; and flexibility. Unlike international health, BRICS health collaborations are not primarily concerned with preventing the importation of infectious disease across national borders. Nor are they based on global health's concerns about global biosecurity or humanitarian biomedicine. Rather, BRICS collaborative health efforts fall within the nation-state paradigm, while also aspiring towards the global. They remain flexible in their operation, gesturing towards a neoliberal ethic. This flexibility allows BRICS to work within existing structures, while also establishing their own institutions from which to change traditional assistance relationships.

show abstract

“…5 The countries are also moving towards universal health coverage, although without any uniform approach and at an uneven pace. [6][7][8] Brazil, China and India are leading in the manufacturing of low-cost medicines and vaccines. 9 In just a few years BRICS have amassed a wealth of experience in universal health coverage and low-cost medicines and vaccines from which other low-and middle-income countries can draw valuable examples.…”

mentioning

confidence: 99%